Placebo-controlled Comparison of the Efficacy and Tolerability of Once-daily Moxonidine and Enalapril in Mild to Moderate Essential Hypertension

By Prichard Brian N. C.   Jäger Bodo A.   Luszick Joachim H.   Küster Leslie J.   Verboom Caes N.   Hughes Peter R.   Sauermann Wilhelm   Küppers Hartmut E.  

Blood Pressure, Vol. 11, Iss. 3, 2002-05 ,pp. : 166-172

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Once-daily Barnidipine in the Clinical Management of Patients with Mild to Moderate Essential Hypertension

By SPIEKER CLAUS  

Blood Pressure, Vol. 7, Iss. 1, 1998-06 ,pp. : 15-21

Informa Healthcare

Access to resources Recommend Favorite

Once-Daily Administration of Budesonide Turbuhaler® was as Effective as Twice-Daily Treatment in Patients with Mild to Moderate Persistent Asthma

By Mintz Sheldon   Alexander Michael   Li John   Mayer Perry  

Journal of Asthma, Vol. 39, Iss. 3, 2002-05 ,pp. : 203-210

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, 16 mg, Provides a Greater Antihypertensive Effect than Losartan, 50 mg, in Patients with Mild to Moderate Hypertension

By ANDERSSON O. K.   NELDAM S.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 55-55

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of once-daily GW870086 a novel selective glucocorticoid in mild-moderate asthmatics: a randomised, two-way crossover, controlled clinical trial

By Bareille Philippe   Hardes Kelly   Donald Alison C.  

Journal of Asthma, Vol. 50, Iss. 10, 2013-12 ,pp. : 1077-1082

Informa Healthcare

Access to resources Recommend Favorite